Biosynex SA reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 382.5 million compared to EUR 153.9 million a year ago. Net income was EUR 104 million compared to EUR 31.4 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 EUR | -0.47% | +1.94% | -49.70% |
Apr. 30 | Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 29 | Biosynex: agreement for ProciseDx in North America | CF |
1st Jan change | Capi. | |
---|---|---|
-49.70% | 48.58M | |
-1.89% | 12.5B | |
-9.59% | 7.67B | |
+21.82% | 5.36B | |
-1.31% | 5.26B | |
+0.02% | 4.57B | |
-50.89% | 3.15B | |
+6.42% | 2.59B | |
-10.02% | 2.06B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2021